Articles tagged with Tuberculosis
Researchers have uncovered why a relatively new antibiotic for tuberculosis works against multidrug-resistant strains by identifying deficiencies in a critical enzyme. This discovery could lead to improved treatments and drug development strategies, potentially allowing for lower doses or shorter treatment times.
A research team led by Dr. Bernd Meibohm is working on developing new treatments for tuberculosis that require fewer pills, shorter treatment periods, and reduce the risk of resistance. They aim to replace linezolid with Spectinamide 1810, a safer alternative that can be administered directly to the lungs.
A new study published in The Lancet Child & Adolescent Health found that children living in areas with a high burden of tuberculosis have a consistently high annual risk of developing TB infection throughout childhood. By age 10, over 10% of children developed TB disease.
Researchers discovered that tuberculosis alters liver metabolism and can push patients towards metabolic disease like diabetes. The study suggests undiagnosed TB could be a significant contributor to metabolic health issues.
Researchers at Texas Biomedical Research Institute developed a human cell culture model of alveolar macrophages, which helped make a key finding about the role of tumor necrosis factor (TNF) in tuberculosis (TB). The study found that TNF is critical to protect against TB but not other infectious diseases.
A new study has discovered a novel semi-synthetic compound derived from natural compounds that exhibits potent activity against Mycobacterium tuberculosis, including multi-drug resistant strains. The compound, BPD-9, provides a promising chemical scaffold for developing new anti-tuberculosis drugs.
African wormwood, a plant used for centuries to treat various illnesses, contains a compound that can kill the bacteria causing tuberculosis. Researchers have identified this compound, an O-methylflavone, as effective against both active and inactive states of the mycobacterium.
Researchers at Texas Biomedical Institute have developed a TB therapy that does not interfere with combined antiretroviral therapy (cART) in patients with HIV. The host-directed therapy blocks an immune system protein and has shown improved control of TB when used with antibiotics.
After analyzing human immune cells and TB patients, researchers found that TCA metabolism plays a crucial role in DNA methylation. Adding an inhibitor of TCA activation reduced detrimental marks, suggesting epigenetic healing is possible. This discovery may lead to new treatment strategies for infectious diseases.
A recent study found that racial and ethnic tuberculosis (TB) disparities among US-born persons can result in significant long-term health consequences. The research indicates that these disparities can have substantial effects on the economy as well, potentially affecting TB elimination goals within the US.
Researchers identified a genetic cause of TNF deficiency, which incapacitates a specific immune process in the lungs, leading to targeted and severe illness. This finding may upend long-held assumptions about the immune system and have far-reaching clinical implications.
Researchers discovered a non-virulent bacterium, Mycobacterium spongiae, that shares 80% of its genetic material with M. tuberculosis, shedding light on the disease's origins. The study provides valuable insights into the evolution and virulence of TB.
A subset of CD4 T cells create an anti-inflammatory environment within the lung tissue, protecting against TB reinfection by limiting bacterial growth and disease severity. The discovery complements previous research on protective immune T cells in controlling TB infection, suggesting a potential key to improving existing vaccines.
A study analyzing 5.5 million EU/EEA infectious disease cases over 10 years found significant sex differences in notified male versus female cases for several diseases. The proportion of males ranged from 40-45% for pertussis and Shiga toxin-producing Escherichia coli infections to 75-80% for HIV/AIDS.
Researchers found that macrophages induce cancer cell apoptosis and then eat away dead cells after BCG vaccine injection in a new animal model. This breakthrough could lead to more effective bladder cancer treatments.
Researchers found that close household contacts of people diagnosed with geographically restricted TB strains had a lower rate of infection and active TB disease compared to those exposed to widespread lineages. This suggests a shared evolution between humans and microbes, amplifying the risk for infection.
A new study by UC Davis researchers found that male gender and residency in large towns are the strongest risk factors for active TB progression in South Africa. Higher socioeconomic status, age, and migration history also impact active TB risk.
Researchers have identified a group of molecules called callyaerins that can act against tuberculosis by targeting a specific membrane protein of the bacterium Mycobacterium tuberculosis. These substances inhibit bacterial growth without affecting human cells, offering a promising new approach to treating the disease.
Human lung organoids can form lifelike models for tuberculosis infection, enabling the testing of anti-tuberculosis drugs. These models may also facilitate the development of host-directed therapies.
Scientists from Hackensack Meridian Health have identified a new potential pathway for developing vaccines against tuberculosis by targeting marginal zone B (MZB) cells, a natural response to TB infection. The discovery suggests that boosting MZB cell activity could provide reliable and durable protection against the disease.
Researchers at Butantan Institute and collaborators developed a more potent version of the BCG vaccine, which protects against tuberculosis by inducing a strong immune response. The new formulation protected animals for a significantly longer period than conventional BCG.
Researchers have designed a novel 3D hydrogel culture system that accurately mimics the mammalian lung environment, allowing for the study of tuberculosis bacteria infection and therapeutics. The system successfully tracks infection progression and demonstrates the efficacy of pyrazinamide in clearing out TB bacteria.
Researchers at the University of the Witwatersrand have developed a modified BCG vaccine that shows enhanced protection against tuberculosis in mice. The new vaccine candidate could potentially replace or boost existing TB vaccines, providing a novel solution to the global health crisis.
Scientists have developed a new method to detect antibiotics in finger sweat, showing high accuracy for tuberculosis treatment monitoring. The technique allows for less invasive testing, making it easier to monitor treatment and preventing drug-resistant TB.
The American College of Chest Physicians' CHEST Critical Care and CHEST Pulmonary journals have been indexed with the Directory of Open Access Journals (DOAJ), enhancing their open access content's accessibility and usage. The indexation is attributed to strong editorial boards led by Hayley Gershengorn and Matthew Miles.
A new study suggests that countries should prioritize tuberculosis treatment for exposed individuals with evidence of TB infection, regardless of age—except in high-burden settings, where all exposed individuals should be considered for treatment. Preventive treatment can stop latent TB infections from developing into deadly TB disease.
New therapies aim to strengthen the body's immune responses and restore antimicrobial functions to combat TB. Researchers have identified small molecule compounds that reduce Mtb growth inside immune cells by up to 50-75%, suggesting a potential complement to standard therapy.
Researchers found that undernourished household contacts were three times more likely to progress to TB disease than well-nourished individuals. The study suggests that undernutrition fails to contain the infection when it occurs, leading to increased risk of severe illness and death.
Researchers uncover how tuberculosis infection drives excessive inflammation in the lungs by activating neutrophils. Targeting neutrophils could lead to new therapies for TB treatment, potentially reducing antibiotic-resistant cases.
A study of tens of thousands of individuals found that post-TB lung disease is a significant global challenge. TB survivors experience restrictive lung damage and airflow obstruction, reducing their ability to breathe efficiently and increasing the risk of cardiovascular and respiratory diseases.
A study found that structural racism is largely to blame for disparities in tuberculosis (TB) incidence among the U.S.-born population. Researchers analyzed national TB registry data and found that TB incidence ratios were higher for certain racial and ethnic groups, with greater relative disparities among females.
A population-wide observational study found an association between tuberculosis (TB) and a higher incidence of various cancers. TB patients were more likely to be diagnosed with lung, blood, gynaecological, colorectal, thyroid, oesophagus, and stomach cancers compared to the general population.
A new study finds that BCG vaccination reduces TB transmission in cattle by almost 90%. Vaccinated cows also develop significantly fewer visible signs of TB than unvaccinated ones. The vaccine has the potential to control bovine tuberculosis and put herds on a pathway towards elimination.
Researchers at Massachusetts General Hospital successfully repurposed approved drugs to improve drug delivery to tuberculosis bacteria, promoting anti-bacterial host responses and improving health outcomes. The study found that combining bevacizumab and losartan enhanced TB drug delivery and reduced bacterial burden in rabbits with TB.
A new study published in Microbiology Spectrum shows that an enzymatic cocktail can effectively kill a variety of mycobacterial species, including those causing tuberculosis. The research delivers the enzymes inside host macrophages where mycobacteria grow, increasing efficacy and reducing toxicities associated with current treatments.
Researchers have identified a combination of medications that may improve blood flow within granulomas, benefiting drug delivery and reducing bacterial burden in tuberculosis-infected rabbits. The study leverages decades of cancer research to study tuberculosis-affected lung tissue and improves treatment.
Researchers have developed new recommendations for optimizing TB screening programs in low-incidence countries. Screening high-risk groups, such as migrants and vulnerable populations, is a cost-effective approach that detects the disease early and prevents transmission.
Researchers have developed a new framework for classifying tuberculosis (TB) that replaces the traditional binary approach with four disease states: clinical, subclinical, infectious, and non-infectious. The International Consensus for Early TB (ICE-TB) framework aims to improve diagnosis and treatment of early-stage TB, which has hist...
Scientists have discovered six proteins that can accurately diagnose tuberculosis (TB). The breakthrough study paves the way for a simple blood test to detect the bacteria, which could prevent millions of cases annually. TB is the world's deadliest infectious disease, killing over one million people each year.
A systematic review by Gogichadze et al. suggests that active pulmonary TB screening programs targeting vulnerable populations in low-TB-incidence countries are cost-effective. The authors conclude that screening immigrants and other high-risk groups is a viable approach to detecting latent infections.
Tulane University researchers have developed a CRISPR-based platform for diagnosing nontuberculous mycobacteria (NTM) infections, allowing for accurate results in as little as two hours. The blood test can identify over 93% of patients with an NTM infection, enabling rapid treatment plans and reducing the risk of complications.
Research on over 600,000 TB cases reveals 80% have no persistent cough, delaying diagnoses and transmission, with high infection rates among symptomless individuals. The study suggests rethinking current diagnostic practices for more effective TB identification.
A study by Amsterdam UMC and University of Cape Town found that Mycobacterium tuberculosis is present in the respiratory aerosol of 90% of suspected TB patients, including those with negative sputum tests. This raises concerns about unknowingly transmitting infection and highlights the complexity of TB transmission.
The Access to Advanced Health Institute (AAHI) has received $12.7 million to develop a novel immune-stimulating adjuvant formulation, NanoAlum, which aims to improve vaccine protection against complex diseases like tuberculosis and influenza.
A network of African scientists has secured funding to develop new drugs for malaria and TB, two major diseases affecting the continent. The Grand Challenges Africa Drug Discovery Accelerator Programme will support leading research efforts on these diseases.
Researchers at Weill Cornell Medicine found that patients with drug-resistant tuberculosis (TB) respond similarly to those with drug-sensitive TB when treated with bedaquiline-based second-line medications. The study suggests that treatment duration for drug-resistant TB may be shortened, potentially reducing mortality rates.
Researchers at McGill University Health Centre discovered that a century-old BCG vaccine can provide cross-protection against influenza A virus and COVID-19 by inducing trained immunity. The study's findings have significant implications for developing vaccines against emerging respiratory viruses.
Researchers found that an imbalance of CD4+ T cells in the lungs can exacerbate tuberculosis, leading to increased disease severity and reduced survival rates. Removing a specific receptor that recognizes extracellular ATP can improve the response of these T cells and potentially lead to new therapeutic interventions.
A new study from the University of Cincinnati finds that being in prison is a significant driver of multidrug-resistant tuberculosis (MDR-TB) transmission. The researchers identified molecular resistance patterns and defined recent transmissions, highlighting the need for targeted interventions to control the MDR-TB epidemic in prisons.
Researchers at La Jolla Institute for Immunology have identified 137 unique T cell epitopes targeted by the immune system in patients with active TB. These findings may lead to the development of new diagnostics and therapies for the disease, which affects over 1.3 million people worldwide.
The University of Texas at Arlington is advancing its understanding of deadly disease tuberculosis (TB) with a new research project led by associate professor Kayunta Johnson-Winters. The project aims to understand why certain types of Mycobacterium tuberculosis bacteria do not respond to treatments.
Researchers developed a new method to identify individuals at high risk of developing tuberculosis, using PET-CT imaging and a novel bacteriophage-based assay. The study identified 20 asymptomatic contacts who were subsequently tested for TB through bronchoscopy and sampling.
A team of researchers from UMass Amherst and Seattle Children's Research Institute found that prior exposure to certain bacteria changes the lung's innate immune response, making it more vulnerable to tuberculosis. The study suggests that remodeling the innate immune system could be a more effective strategy in fighting TB.
A study in Paraguay found that people deprived of liberty are at a high risk of tuberculosis (TB) during and after incarceration. The risk persists for years after release, with the incidence of TB declining but remaining 10 times higher than in the community.
A review paper highlights N-AIDS as a key determinant and comorbidity of TB, emphasizing the need for action on malnutrition to detect, prevent, and eliminate TB. The study found that nutritional interventions can significantly reduce TB incidence among household contacts.
Researchers have found that the BCG vaccine can enhance innate immunity in individuals with dormant immune cells, predicting a positive response to vaccination. Trained immunity responders exhibited increased production of inflammatory mediators after vaccination.
Researchers discovered new antibiotic molecules targeting Mycobacterium tuberculosis, reducing its pathogenicity. These substances also enhance the activity of conventional antibiotics like ethionamide, offering a renewed treatment approach.
Researchers found a single gene involved in iron-sulphur clusters crucial for TB bacterium's persistence. The IscS gene helps regulate the SUF operon, preventing hypervirulence and allowing the bacteria to survive harsh lung conditions.
Recent studies published in the Tuberculosis journal reveal the earliest confirmed presence of tuberculosis' causative agents in human remains, pushing the timeline back by tens of thousands of years. Researchers have also discovered evidence of TB infection in Neanderthal specimens from Hungary, dating back over 32,000 years.
Nanoparticles loaded with antibiotics and antimicrobial compounds inhibit TB progression and overcome resistance without cell damage. The technology shows promise for a shorter treatment strategy against multidrug-resistant strains of Mycobacterium tuberculosis.